It looks as though Eliquis, the new bloodthinner being developed by Bristol-Myers Squibb and Pfizer, has lived up to all the hype. Data from a closely watched clinical trial, presented at a cardiology ...

Is Pfizer ($PFE) and Bristol-Myers Squibb's ($BMY) Eliquis really safer than its competitors? A recent analysis of FDA adverse events reports suggested that it is ...

The company said 300,000 people have been prescribed the drug so far. And in the long term, even if Xarelto gets the FDA nod, Pradaxa may keep a bigger share than it otherwise might; Morningstar is ...

For millions of heart patients, a pair of new blood thinners have been heralded as the first replacements in 60 years for warfarin, a pill whose hardships and risks have deterred many from using the ...

It might be more than a year from now, but litigation centered on the blood thinner Xarelto could eventually come to trial in Philadelphia courtrooms – and one attorney says the thousands of cases ...

MONDAY, Oct. 3, 2016 -- The blood thinner Xarelto may pose a slightly greater risk of serious bleeding than Pradaxa in patients with the abnormal heartbeat known as atrial fibrillation, new research ...

Johnson & Johnson and Bayer AG‘s blood thinner Xarelto prevented strokes in patients with an erratic heartbeat better than standard therapy with warfarin in a study, without raising the risk of ...

This post is part of an ambitious project to crowd-source the December issue of Forbes Magazine. Click here to submit your own ideas for “Names You Need to Know in 2011.” The best will run in the ...

NEW YORK (Reuters) - For millions of heart patients, a pair of new blood thinners have been heralded as the first replacements in 60 years for warfarin, a pill whose hardships and risks have deterred ...